South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032
Overview
The South Korea Non-Small Cell Lung Cancer Diagnostics Market is expected to reach a 82.72 USD Million by 2032 and is projected to grow at a CAGR of 24.94% from 2025 to 2032.
Revenue, 2024 (USD Million)
26.31
Forecast, 2032 (USD Million)
82.72
CAGR, 2024 - 2032
24.94%
Report Coverage
South Korea
South Korea Non-Small Cell Lung Cancer Diagnostics Market 2018-2032 USD Million
South Korea Non-Small Cell Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 26.31 USD Million
- Projected Market Size (2032): 82.72 USD Million
- CAGR (2025-2032): 24.94%
Key Findings of South Korea Non-Small Cell Lung Cancer Diagnostics Market
- The South Korea Non-Small Cell Lung Cancer Diagnostics Market was valued at 26.31 USD Million in 2024.
- The South Korea Non-Small Cell Lung Cancer Diagnostics Market is likely to grow at a CAGR of 24.94% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Molecular Test in Test Segment accounted for the largest share of the market with a revenue of 13.92 USD Million
- The fastest growing segment Imaging Test in Test Segment grew Fastest with a CAGR of 28.49% during the forecast period from 2024 to 2032.
South Korea Non-Small Cell Lung Cancer Diagnostics Market Scope
South Korea Non-Small Cell Lung Cancer Diagnostics Market Segmentation & Scope
Test
- Thorecentesis
- Sputum Cytology
- Biopsy
- Immunohistochemistry
- Others
- Imaging Test
- Molecular Test
End User
- Institutes and Research Centers
- Academics
- Hospital
- Clinical Laboratories
Lung Cancer Type
- Others
- Large Cell Carcinoma
- Lung Squamous CellCarcinoma (LUSC)
- Lung Adenocarcinoma (LUAD)
Product
- Services and Softwares
- Reagents and Kits
- Instruments
South Korea Non-Small Cell Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 26.31 USD Million |
| Market Value in 2032 | 82.72 USD Million |
| CAGR (2025-2032) | 24.94% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test,End User,Lung Cancer Type,Product |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 26.31 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 26.31 USD Million in 2024.
Segments and Scope
-
South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Test
- Molecular Test is the largest segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 13.92 USD Million in the year 2024.
- Imaging Test is the Fastest growing segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 25.02 % in forecast period 2025-2032.
-
South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032, By End User
- Clinical Laboratories is the largest segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 9.30 USD Million in the year 2024.
- Clinical Laboratories is the Fastest growing segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 26.51 % in forecast period 2025-2032.
-
South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Lung Cancer Type
- Lung Adenocarcinoma (LUAD) is the largest segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 13.43 USD Million in the year 2024.
- Lung Adenocarcinoma (LUAD) is the Fastest growing segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 25.42 % in forecast period 2025-2032.
-
South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a revenue of 11.76 USD Million in the year 2024.
- Reagents and Kits is the Fastest growing segment in South Korea Non-Small Cell Lung Cancer Diagnostics Market to 2032 with a Growth rate of 24.46 % in forecast period 2025-2032.
South Korea Non-Small Cell Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| QIAGEN | |||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
South Korea Non-Small Cell Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Non-Small Cell Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
South Korea Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 26.31(Revenue in USD Million) in 2020.
South Korea Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 24.94% during the forecast period of 2024 to 2032.
The Molecular Test segment is expected to dominate the South Korea Non-Small Cell Lung Cancer Diagnostics Market, holding a largest market share of 13.92 USD Million in 2024
South Korea Non-Small Cell Lung Cancer Diagnostics Market Scope
South Korea Non-Small Cell Lung Cancer Diagnostics Market Segmentation & Scope
Test
- Thorecentesis
- Sputum Cytology
- Biopsy
- Immunohistochemistry
- Others
- Imaging Test
- Molecular Test
End User
- Institutes and Research Centers
- Academics
- Hospital
- Clinical Laboratories
Lung Cancer Type
- Others
- Large Cell Carcinoma
- Lung Squamous CellCarcinoma (LUSC)
- Lung Adenocarcinoma (LUAD)
Product
- Services and Softwares
- Reagents and Kits
- Instruments
Frequently Asked Questions
The South Korea Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
South Korea Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 26.31(Revenue in USD Million) in 2020.
South Korea Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 24.94% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Non-Small Cell Lung Cancer Diagnostics Market for final year is USD 82.72 (USD Million).
South Korea Non-Small Cell Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The South Korea Non-Small Cell Lung Cancer Diagnostics Market is segmented based on Segmentation Test,End User,Lung Cancer Type,Product.
South Korea Non-Small Cell Lung Cancer Diagnostics Market was valued at USD 26.31(Revenue in USD Million) in 2020.
South Korea Non-Small Cell Lung Cancer Diagnostics Market is projected to grow at a CAGR of 24.94% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Non-Small Cell Lung Cancer Diagnostics Market for final year is USD 82.72 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.